This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pharma Clinical Trial Services: World Market 2013-2023

Table 4.6 Western European Clinical Trial Services Market: Revenue Forecasts by Country, 2011-2023

Table 4.7 German Clinical Trial Services Market Forecast, 2011-2023

Table 4.8 French Clinical Trial Services Market Forecast, 2011-2023

Table 4.9 UK Clinical Trial Services Market Forecast, 2011-2023

Table 4.10 Italian Clinical Trial Services Market Forecast, 2011-2023

Table 4.11 Spanish Clinical Trial Services Market Forecast, 2011-2023

Table 4.12 Japanese Clinical Trial Services Market Forecast, 2011-2023

Table 5.1 Leading Emerging Markets for Pharma Clinical Trial Services, 2011

Table 5.2 Population Statistics in BRIC Nations, 2012

Table 5.3 Relative Competence in English in Emerging Markets, 2012

Table 5.4 Pharma Clinical Trial Services Market: Revenue Forecasts in Emerging Markets, 2011-2023

Table 5.5 Indian Clinical Trial Services Market Forecast, 2011-2023

Table 5.6 Chinese Clinical Trial Services Market Forecast, 2011-2023

Table 5.7 South Korean Clinical Trial Services Market Forecast, 2011-2023

Table 5.8 Russian Clinical Trial Services Market Forecast, 2011-2023

Table 5.9 CEE Clinical Trial Services Market Forecast, 2011-2023

Table 5.10 Brazilian Clinical Trial Services Market Forecast, 2011-2023

Table 6.1 Global Clinical Trials by Therapeutic Area, 2012

Table 6.2 Leading Therapeutic Areas for Clinical Trial Services, 2011

Table 6.3 Clinical Pipelines for Leading Therapeutic Areas, 2010-2012

Table 6.4 Pharma Clinical Trial Services Market: Revenue Forecasts for Leading Therapeutic Areas, 2011-2023

Table 6.5 Leading CROs Specialising in Biomarker Services, 2012

Table 6.6 Cancer Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.7 Cancer Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.8 Late-Stage Pipeline Failures in Alzheimer's Disease, 2009-2012

Table 6.9 CNS Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.10 CNS Disease Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.11 Cardiovascular Disease Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.12 Cardiovascular Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.13 Chronic Hepatitis B & C: Global Prevalence by Region, 2012

Table 6.14 Infectious Disease Clinical Trial Services Submarket Forecast, 2011-2023

8 of 13

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs